title: Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells.
abstract: Graft rejection by the immune system is a major cause of transplant failure. Lifelong immunosuppression decreases the incidence of graft rejection; however, nonspecific immunosuppression results in increased susceptibly to infection and cancer. Regulatory T cells (T(regs)), which suppress the activation of the immune system and induce tolerance, are currently under evaluation for use in clinical transplantation. Ex vivo expanded polyclonal T(regs) that are introduced into transplant recipients alter the balance of T effector cells to T(regs); however, experimental data suggest that alloantigen-specific T(regs) would be more effective at preventing graft rejection. We have developed a method to enrich alloantigen-specific human T(regs) based on the coexpression of activation markers, CD69 and CD71. These T(regs) could be readily expanded in vitro and demonstrated potent antigen-specific suppression. In a humanized mouse model of alloimmune-mediated injury of human skin grafts, alloantigen-specific T(regs) resulted in a significant reduction in clinically relevant indicators of dermal tissue injury when compared with polyclonal T(regs), restoring a histology comparable to healthy skin. This method of human allospecific T(reg) selection should be scalable to the clinic. The improved in vivo efficacy of alloantigen-specific T(regs) over polyclonal T(regs) shown here suggests that generating "customized" T(regs) with defined anti-donor allospecificities may improve current practice in clinical immunotherapy.
authors: MRC Centre for Transplantation, King's College London, SE1 9RT London, UK.
authors: Pervinder
authors: P
authors: Sagoo
authors: Niwa
authors: N
authors: Ali
authors: Garima
authors: G
authors: Garg
authors: Frank O
authors: FO
authors: Nestle
authors: Robert I
authors: RI
authors: Lechler
authors: Giovanna
authors: G
authors: Lombardi
references: Transplantation. 2010 Mar 15;89(5):527-36
references: 20134397
references: Am J Transplant. 2004 Mar;4(3):378-83
references: 14961990
references: Nat Immunol. 2006 Jan;7(1):83-92
references: 16311599
references: Nat Rev Immunol. 2010 Jul;10(7):490-500
references: 20559327
references: Am J Transplant. 2011 Mar;11(3):450-62
references: 20973913
references: Blood. 2007 Jan 15;109(2):827-35
references: 17003369
references: J Exp Med. 2002 Aug 5;196(3):389-99
references: 12163567
references: Rheumatol Int. 2012 May;32(5):1147-54
references: 21249500
references: Stem Cells. 1994 Sep;12(5):456-65
references: 7804122
references: J Exp Med. 2006 Jul 10;203(7):1701-11
references: 16818678
references: Immunity. 2009 Jun 19;30(6):899-911
references: 19464196
references: Bone Marrow Transplant. 2006 Feb;37(3):297-305
references: 16327814
references: Nat Med. 2010 Jul;16(7):809-13
references: 20473306
references: Nat Rev Immunol. 2008 Jul;8(7):523-32
references: 18566595
references: Transplantation. 2010 Dec 27;90(12):1321-7
references: 21048528
references: Tissue Antigens. 1995 Nov;46(5):355-67
references: 8838344
references: Cell Prolif. 2009 Dec;42(6):780-7
references: 19689471
references: Blood. 2007 Aug 15;110(4):1225-32
references: 17449799
references: Nat Med. 2007 Jul;13(7):836-42
references: 17603494
references: Blood. 2010 Jan 14;115(2):396-407
references: 19890093
references: J Immunol. 2009 Sep 15;183(6):4094-102
references: 19684083
references: Br J Haematol. 2000 Jun;109(3):644-51
references: 10886218
references: Nat Rev Immunol. 2007 Feb;7(2):118-30
references: 17259968
references: Diabetes. 2009 Mar;58(3):652-62
references: 19074986
references: Exp Biol Med (Maywood). 2003 Oct;228(9):1096-104
references: 14530522
references: Transplantation. 2010 Dec 27;90(12):1547-55
references: 21085066
references: J Immunol. 2009 Dec 1;183(11):7602-10
references: 19917691
references: Curr Opin Organ Transplant. 2008 Dec;13(6):645-53
references: 19060557
references: Hum Immunol. 2008 Jul;69(7):389-98
references: 18638654
references: PLoS One. 2008 May 21;3(5):e2233
references: 18493605
references: Sci Transl Med. 2009 Oct 7;1(1):1ra3
references: 20368155
references: Transpl Immunol. 2009 Sep;21(4):203-9
references: 19446634
references: J Immunol. 2008 May 15;180(10):6640-8
references: 18453583
references: J Immunol. 2006 Apr 15;176(8):4622-31
references: 16585553
references: Clin Immunol. 2009 Oct;133(1):22-6
references: 19559653
references: Curr Opin Organ Transplant. 2010 Aug;15(4):427-34
references: 20616725
references: J Immunol. 1993 Dec 1;151(11):6535-45
references: 7504023
references: J Clin Invest. 2008 Nov;118(11):3619-28
references: 18846251
references: J Immunol. 2005 Jun 15;174(12):7573-83
references: 15944257
references: Nat Med. 2008 Jan;14(1):88-92
references: 18066074